Sign in
CompletedNo phase

Exploring the Impact of Dynamic Defocus Display Schemes on Ocular Health Indicators

Key facts

Who runs it
Beijing Tongren Hospital
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
36 people enrolled
Started
20 Aug 2025
Ended
30 Nov 2025
Type of study
Interventional, 5 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Dynamic Defocus Mode
Record updated
18 December 2025

Who can take part

Age
20 years to 40 years
Sex
Women and men
Healthy volunteers
Can take part
Show the full registry criteria (11)Hide the full registry criteria

Who can take part

  • Adults aged between 20 and 40 years, regardless of gender
  • Refractive anisometropia ≤2.5D and corrected visual acuity of 1.0 or above in both eyes
  • Habitual long-term use of electronic devices with LED light sources, such as computers and smartphones
  • Currently not using any other blue light protection products or having ceased the use of such products for at least 2 weeks
  • No known visually significant ophthalmic diseases
  • Willing to participate in the trial and having signed the informed consent form

Who cannot take part

  • Severe dry eye or history of ocular medication use
  • Acute or chronic ocular surface inflammation, keratoconus, history of ocular surgery (e.g., refractive surgery), systemic diseases, or other conditions (e.g., wearing orthokeratology lenses and using atropine)
  • Photosensitivity, history of epilepsy, etc
  • Abnormal accommodative function or other visual function abnormalities (e.g., strabismus, amblyopia)
  • Individuals unable to cooperate with the examination

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The present study is designed to explore the effects of dynamic defocus display technology on ocular health parameters using rigorous scientific approaches. It further examines the mechanisms through which this technology alleviates visual fatigue, thereby providing robust clinical evidence to support its practical application and widespread adoption.

The 5 groups in the trial

  • Control groupNo study treatment, for comparison

    This group serves as the baseline comparison. Participants will perform the video-watching task on a conventional display with no intervention, allowing for the assessment of typical visual fatigue and ocular health indicators under standard conditions.

  • Intervention Group A (Low defocus amplitude and high frequency)Treatment being tested

    Participants will use a display with Dynamic Defocus Mode with low defocus amplitude and high frequency to perform a video browsing task. This group is designed with a specific dynamic defocus adjustment scheme, aimed at investigating the extent to which different dynamic defocus schemes can improve visual fatigue. Participants will be single-blinded to their group assignment. The intervention involves Dynamic Defocus Mode 1 and follows the VDT task protocol as designed in the trial.

    Treatment: Dynamic Defocus Mode

  • Intervention Group B (low defocus amplitude and low frequency)Treatment being tested

    Participants will use a display with Dynamic Defocus Mode with low defocus amplitude and low frequency to perform a video browsing task. This group is designed with a specific dynamic defocus adjustment scheme, aimed at investigating the extent to which different dynamic defocus schemes can improve visual fatigue. Participants will be single-blinded to their group assignment. The intervention involves Dynamic Defocus Mode 1 and follows the VDT task protocol as designed in the trial.

    Treatment: Dynamic Defocus Mode

  • Intervention Group C (high defocus amplitude and high frequency)Treatment being tested

    Participants will use a display with Dynamic Defocus Mode with high defocus amplitude and high frequency to perform a video browsing task. This group is designed with a specific dynamic defocus adjustment scheme, aimed at investigating the extent to which different dynamic defocus schemes can improve visual fatigue. Participants will be single-blinded to their group assignment. The intervention involves Dynamic Defocus Mode 1 and follows the VDT task protocol as designed in the trial.

    Treatment: Dynamic Defocus Mode

  • Intervention Group D (high defocus amplitude and low frequency)Treatment being tested

    Participants will use a display with Dynamic Defocus Mode with high defocus amplitude and low frequency to perform a video browsing task. This group is designed with a specific dynamic defocus adjustment scheme, aimed at investigating the extent to which different dynamic defocus schemes can improve visual fatigue. Participants will be single-blinded to their group assignment. The intervention involves Dynamic Defocus Mode 1 and follows the VDT task protocol as designed in the trial.

    Treatment: Dynamic Defocus Mode

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
18 December 2025